SCHEMBL2853843

SCHEMBL2853843

NC1C=CC=CC1(Cl)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903181 0.74
SCHEMBL1441894 0.74
SCHEMBL9764673 0.74
SCHEMBL1459722 0.72
SCHEMBL262103 0.72
SCHEMBL1775067 0.72
SCHEMBL3589631 0.72
SCHEMBL12497498 0.70
SCHEMBL11157039 0.69
SCHEMBL3726216 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103237801-B Quinoline or quinazoline derivatives having apoptosis-inducing activity on cells HANMI HOLDINGS Co.,Ltd. (KR) 2015-11-25 CN claimed
US-20250382277-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543887-A2 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
CN-117926291-A Method for preparing bromoarene by taking bromopollutant as bromine source through photoelectrocatalysis 中国科学院化学研究所 2024-04-26 CN disclosed
WO-2023250082-A2 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed
CN-104774188-B Benzo-heterocycle or benzo hetero-aromatic ring analog derivative, preparation method and its application in medicine 江苏恒瑞医药股份有限公司 2019-10-11 CN disclosed
CN-104892582-B Azetidine as the mek inhibitor for treating proliferative disease 埃克塞利希斯股份有限公司 2019-09-27 CN disclosed
CN-110267953-A Tetrahydroimidazo [4,5-C ] pyridine derivatives as inducers of PD-L1 internalization 因赛特公司 2019-09-20 CN disclosed
CN-110251498-A One kind adjusts active compound of Farnesoid X receptor and application thereof 厦门大学 2019-09-20 CN disclosed
CN-106518845-B Kynurenin -3- monooxygenase inhibitor, pharmaceutical composition and its application method CHDI基金会股份有限公司 2019-09-13 CN disclosed
CN-102985422-A Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases ABBVIE INC 2013-03-20 CN disclosed
US-8263585-B2 Organic compounds NOVARTIS AG (CH) 2012-09-11 US disclosed
US-8183385-B2 SNAR process for preparing benzimidazole compounds ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100130748-A1 SNAR PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS ARRAY BIOPHARMA INC. (US) 2010-05-27 US disclosed
US-20090163463-A1 Organic Compounds NOVARTIS AG 2009-06-25 US disclosed
EP-2057140-A1 MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2009-05-13 EP disclosed
WO-2008089051-A1 N-SUBSTITUTED GLYCINE DERIVATIVES: PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-24 WO disclosed
EP-1904061-A1 SNAr PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS Array Biopharma, Inc. (US) 2008-04-02 EP disclosed
WO-2008023159-A1 MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-02-28 WO disclosed
WO-2007002092-A1 SNAr PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS ARRAY BIOPHARMA INC. (US) 2007-01-04 WO disclosed